Lurbinectedin (PM01183) activity in BRCA1/2-associated or unselected metastatic breast cancer. Interim results of an ongoing phase II trial Meeting Abstract


Authors: Balmna, J.; Cruz, C.; Garber, J.; Fidalgo, J. A. P.; Lluch, A.; Tung, N.; Antolin, S.; Fernandez, C.; Kahatt, C.; Szyldergemajn, S.; Matos, A. S.; Extremera, S.; Baselga, J.; Isakoff, S. J.
Abstract Title: Lurbinectedin (PM01183) activity in BRCA1/2-associated or unselected metastatic breast cancer. Interim results of an ongoing phase II trial
Meeting Title: 37th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS)
Journal Title: Cancer Research
Volume: 75
Issue: 9 Suppl.
Meeting Dates: 2014 Dec 9-13
Meeting Location: San Antonio, TX
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2015-05-01
Language: English
ACCESSION: WOS:000356730202122
PROVIDER: wos
DOI: 10.1158/1538-7445.SABCS14-P3-13-01
Notes: Meeting Abstract: P3-13-01 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jose T Baselga
    484 Baselga